Veeva Development Cloud Streamlining Drug Development Industrywide
Unified application suites for clinical, regulatory, quality, and safety eliminate siloes to increase efficiency and improve compliance
News provided by
Share this article
Share this article
PLEASANTON, Calif., May 19, 2021 /PRNewswire/ A growing number of life sciences companies are adopting Veeva Development Cloud applications from Veeva Systems (NYSE: VEEV) in an industrywide shift to streamline drug development. More than 650 companies use Veeva Development Cloud applications today, and more than 250 are leveraging multiple Veeva Vault applications across functional areas to enable and connect drug development and manufacturing teams.
Veeva Development Cloud brings together suites of unified applications for clinical, regulatory, quality, and safety on a single cloud platform, eliminating organizational siloes. More than 350 companies are accelerating trial execution with Vault Clinical applications, more
Veeva Development Cloud modernise le développement de médicaments à l échelle de l industrie prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.